Fate Therapeutics Receives $1,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3e04fb64-014e-4b5e-b5c7-17fb520e3ee4&Preview=1 -
Date
4/20/2011 -
Company Name
Fate Therapeutics -
Mailing Address
3535 General Atomics Court San Diego, CA 92121 -
Company Description
The company’s revolutionary platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues. Fate’s reprogramming medicine platform involves developing drugs to reprogram mature adult cells into stem cells which when differentiated can become healthy heart, bone, brain or other tissues. -
Website
http://www.fatetherapeutics.com -
Transaction Type
Debt -
Transaction Amount
$1,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
